about
Humanized hemato-lymphoid system miceUpdate on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesPredicting Mouse Liver Microsomal Stability with "Pruned" Machine Learning Models and Public Data.A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell ActivityHematopoiesis "awakens": Evolving technologies, the force behind them.Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations.Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice.Gene therapy with an AAV vector expressing human IL-2 alters immune system homeostasis in humanized mice.Molecular landscapes of human hematopoietic stem cells in health and leukemia.Turning the tide in myelodysplastic/myeloproliferative neoplasms.Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.Biology and relevance of human acute myeloid leukemia stem cells.Mouse models for pre-clinical drug testing in leukemia.Stem cells and interspecies chimaeras.DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression.Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.Modeling Natural Killer Cell Targeted Immunotherapies.Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice.Myelodysplastic syndrome can propagate from the multipotent progenitor compartment.Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system.The human chorion contains definitive hematopoietic stem cells from the fifteenth week of gestation.Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice.Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche.Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice.The Road Map for Megakaryopoietic Lineage from Hematopoietic Stem/Progenitor Cells.Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia.RUNX1-ETO Leukemia.Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model.Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.Biological Analysis of Human CML Stem Cells; Xenograft Model of Chronic Phase Human Chronic Myeloid Leukemia.Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice.
P2860
Q26771440-7F77470A-7AC0-4CC5-9C03-8E521ACBAF13Q28071384-9A52A163-289B-4A71-803F-48E168A2D495Q30998741-BA07ED96-57D4-41D6-997D-D689A4E7CB12Q34046864-17CFC86F-EBCF-4735-9880-7CBE1365055CQ36080036-DEB89CDF-D1D2-4EA3-BC86-295FFD220CCAQ36522067-56185AAA-FF15-410F-A230-A491835F32F3Q37273984-D3B08EA7-C051-444E-874B-9DE836892B2FQ37381914-2D8F3707-1944-49A7-BD91-0AB377082D00Q37402009-C364E972-4923-4D69-99F1-7CFEC9BD84C2Q38616032-42D8CD5E-4744-47D4-A0E8-A87EEE5167DBQ38668304-755EF594-2A0E-4067-95C2-A7235DB0A8A1Q38712988-791347D1-4CED-44B1-BF7C-CBDAF3E58A19Q38747542-F1D54848-AAC2-45B3-8837-85E9B31B8BC6Q38761783-DA33AE34-1230-4559-B5FC-DA4D5E064A35Q38937610-FACE46D3-C0E5-43B0-A8EF-3DD8A0EE6432Q39025388-16A40568-5D71-41AA-AA57-07A43427E85FQ39196083-29A1A048-50BF-408E-A4F8-EF85BCABA9D4Q39209792-0E8C3093-E3EF-4E83-9741-FF8EB08213DDQ39239278-7548AC74-EBAC-4253-B7FE-7CEA2A4784FAQ39571861-D3172C02-0AD2-4FE8-A995-587ECCB2C1FFQ42334367-4BAFDC94-97C7-4348-AB48-786AF1E17608Q42375720-37E610D0-0C47-4348-9AD3-FE87768454DFQ44807937-C3815458-F9F0-4037-B264-B2BFCEA1D26BQ46087129-2155A533-2AB3-4E32-9214-27CF23DDB458Q46282374-5E16D3FE-3B50-4771-A12C-19D7D45C08A8Q46361829-D8682F44-3FD1-4F49-9928-511E72DD121DQ47648907-43E19673-5DB0-424A-AE50-7F19C01F596DQ47890710-FECE735E-689A-4916-920D-34B46B3BA244Q48036955-4EC310AC-90DC-44F5-A2AB-EBE8CE503D5BQ48101926-FB98A4BF-3124-4F94-B189-17AC63141283Q51097627-9032E8F9-E4D2-4FBB-BDC0-F024E1C1FBA1Q51353105-0A683786-E52C-4652-AA07-48BAA3CF7C53Q54978631-E1C1865F-C43E-4A0C-B02F-F2A962D1F87DQ55016658-2D0925FD-DC33-4B27-ACDD-3EDD2877254AQ55302532-57EC4FF7-621E-4585-8CE8-21756F55D703
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Xenograft models for normal and malignant stem cells
@ast
Xenograft models for normal and malignant stem cells
@en
Xenograft models for normal and malignant stem cells
@nl
type
label
Xenograft models for normal and malignant stem cells
@ast
Xenograft models for normal and malignant stem cells
@en
Xenograft models for normal and malignant stem cells
@nl
prefLabel
Xenograft models for normal and malignant stem cells
@ast
Xenograft models for normal and malignant stem cells
@en
Xenograft models for normal and malignant stem cells
@nl
P2093
P3181
P1433
P1476
Xenograft models for normal and malignant stem cells
@en
P2093
J. C. Mulloy
M. Wunderlich
P304
P3181
P356
10.1182/BLOOD-2014-11-570218
P407
P577
2015-04-23T00:00:00Z